SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.77-3.3%3:43 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (9521)4/4/1999 10:50:00 AM
From: Bluegreen  Read Replies (1) of 17367
 
Now, back to my question. What Biotech would be asked to do the feasibility study? Can anyone come up with some possible names? Bob, what Biotech companies are producing antimicrobial peptides in significant quantities and testing in Phase III trials? Can anyone come up with candidates? Slugger, I have asked several times WHEN was mortality requirement put into effect and has that number changed? BTW Bob, just because animals might produce the peptides DOESN'T have ANYTHING to do with size of protein. GIVE ME A BREAK! How is BPI administered? Isn't it a possibility that instead of producing BPI the way Xoma does, rabbits or some other mammal would do it for you? Get the possible picture now, Bob? It seems you are awful quick to brush aside the above possibilities before you see the feasibility study.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext